Articles published by Renovaro Inc
 
   
    Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
    
   June 03, 2025
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
   
    Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
    
   April 09, 2025
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
   From Renovaro Inc
   Via GlobeNewswire
    
    
    
    
   
    Renovaro Announces $15 million in Equity Committed
    
   February 26, 2025
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro Appoints Nathen Fuentes as Chief Financial Officer
    
   January 07, 2025
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro Issues Shareholder Letter and Provides Corporate Update
    
   January 07, 2025
   From Renovaro Inc
   Via GlobeNewswire
    
    
   
    Renovaro to Acquire Predictive Oncology in All-Stock Transaction
    
   January 06, 2025
   From Renovaro Inc
   Via GlobeNewswire
    
    
   
    Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
    
   December 30, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro Regains Compliance with NASDAQ Listing Requirement
    
   December 20, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
    
   December 20, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro Issues Shareholder Letter and Provides Corporate Update
    
   November 04, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
    
   October 17, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro Announces Strategic Restructuring and Leadership Transition
    
   October 16, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
    
    
   
    RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
    
   September 13, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    RenovaroCube Announces Strategic Offering of Up to 20% Ownership
    
   September 11, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Renovaro, Inc. Announces $10 million in Equity Committed
    
   June 14, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
    
   April 30, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
    
   
    RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
    
   April 24, 2024
   From Renovaro Inc
   Via GlobeNewswire
    Tickers
      RENB
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.